Biden’s TRIPS waiver support won’t guarantee short-run vaccine boost

Coronavirus 492 Health Care 324 India 452 Mexico 815 U.S. 5046

President Biden has committed the U.S. to becoming “the arsenal for fighting COVID-19” with the release of 60 million AstraZeneca vaccine doses for export and support for the relaxation of intellectual property rules under the WTO’s TRIPS Agreement for vaccines. Both are vital for vaccine rollouts in emerging markets as well as in America’s own backyard. Mexican imports of vaccines increased by 104% in March versus the prior three months’ average, with 39.2% of imports accounted for by AstraZeneca and Pfizer. Agreeing new IP rules is likely to take months rather than days to achieve whil...

Copyright © 2021 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.